106 related articles for article (PubMed ID: 10740656)
21. Planar scintimammography and SPECT in neoadjuvant chemo or hormonotherapy response evaluation in locally advanced primary breast cancer.
Spanu A; Farris A; Chessa F; Sanna D; Pittalis M; Manca A; Madeddu G
Int J Oncol; 2008 Jun; 32(6):1275-83. PubMed ID: 18497989
[TBL] [Abstract][Full Text] [Related]
22. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
23. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
[TBL] [Abstract][Full Text] [Related]
24. The use of scintimammography for detecting the recurrence of loco-regional breast cancer: histopathologically proven results.
Bongers V; Perre C; de Hooge P
Nucl Med Commun; 2004 Feb; 25(2):145-9. PubMed ID: 15154703
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-tetrofosmin uptake in sarcoidosis stage I.
Tschabitscher D; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Molnar M; Dinges HP; Kroiss A; Lind P
J Nucl Med; 1997 Nov; 38(11):1786-7. PubMed ID: 9374356
[TBL] [Abstract][Full Text] [Related]
26. The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions.
Spanu A; Ginesu F; Pirina P; Solinas ME; Schillaci O; Farris A; Chessa F; Madeddu G; Marongiu P; Falchi A; Nuvoli S; Madeddu G
Int J Oncol; 2003 Mar; 22(3):639-49. PubMed ID: 12579319
[TBL] [Abstract][Full Text] [Related]
27. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases.
Mansi L; Rambaldi PF; Procaccini E; Gregorio FD; Laprovitera A; Pecori B; Vecchio WD
Eur J Nucl Med; 1996 Aug; 23(8):932-9. PubMed ID: 8753682
[TBL] [Abstract][Full Text] [Related]
28. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
[TBL] [Abstract][Full Text] [Related]
29. Scintimammography with a high resolution dedicated breast camera in comparison with SPECT/CT in primary breast cancer detection.
Spanu A; Chessa F; Sanna D; Cottu P; Manca A; Nuvoli S; Madeddu G
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):271-80. PubMed ID: 18596669
[TBL] [Abstract][Full Text] [Related]
30. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
32. Scintimammography with dedicated breast camera in unifocal and multifocal/multicentric primary breast cancer detection: a comparative study with SPECT.
Spanu A; Cottu P; Manca A; Chessa F; Sanna D; Madeddu G
Int J Oncol; 2007 Aug; 31(2):369-77. PubMed ID: 17611694
[TBL] [Abstract][Full Text] [Related]
33. Mammary lymphoscintigraphy in breast cancer.
Uren RF; Howman-Giles RB; Thompson JF; Malouf D; Ramsey-Stewart G; Niesche FW; Renwick SB
J Nucl Med; 1995 Oct; 36(10):1775-80. PubMed ID: 7562041
[TBL] [Abstract][Full Text] [Related]
34. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran.
Offodile R; Hoh C; Barsky SH; Nelson SD; Elashoff R; Eilber FR; Economou JS; Nguyen M
Cancer; 1998 May; 82(9):1704-8. PubMed ID: 9576292
[TBL] [Abstract][Full Text] [Related]
35. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer.
Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Cannas P; Picardi V; Colella AC
Anticancer Res; 1997; 17(3B):1607-10. PubMed ID: 9179202
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
[TBL] [Abstract][Full Text] [Related]
39. 99mTc labelled cationic lipophilic complexes in malignant and benign tumors: the role of SPET and pinhole-SPET in breast cancer, differentiated thyroid carcinoma and hyperparathyroidism.
Spanu A; Schillaci O; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):145-69. PubMed ID: 16010252
[TBL] [Abstract][Full Text] [Related]
40. [Sentinel lymph node detection in patients with breast carcinoma].
Reuhl T; Haensch W; Markwardt J; Schlag PM
Zentralbl Chir; 1998; 123 Suppl 5():72-4. PubMed ID: 10063579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
